Your browser doesn't support javascript.
loading
Expert panel consensus recommendations on the use of circulating tumor DNA assays for patients with advanced solid tumors.
Imai, Mitsuho; Nakamura, Yoshiaki; Sunami, Kuniko; Kage, Hidenori; Komine, Keigo; Koyama, Takafumi; Amano, Toraji; Ennishi, Daisuke; Kanai, Masashi; Kenmotsu, Hirotsugu; Maeda, Takahiro; Morita, Sachi; Sakai, Daisuke; Bando, Hideaki; Makiyama, Akitaka; Suzuki, Tatsuya; Hirata, Makoto; Kohsaka, Shinji; Tsuchihara, Katsuya; Naito, Yoichi; Yoshino, Takayuki.
Afiliación
  • Imai M; Translational Research Support Section, National Cancer Center Hospital East, Kashiwa, Japan.
  • Nakamura Y; Genomics Unit, Keio University School of Medicine, Tokyo, Japan.
  • Sunami K; Translational Research Support Section, National Cancer Center Hospital East, Kashiwa, Japan.
  • Kage H; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Komine K; Department of Laboratory Medicine, National Cancer Center Hospital, Tokyo, Japan.
  • Koyama T; Department of Next-Generation Precision Medicine Development Laboratory, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Amano T; Department of Medical Oncology, Tohoku University Hospital, Sendai, Japan.
  • Ennishi D; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Kanai M; Clinical Research and Medical Innovation Center, Hokkaido University Hospital, Hokkaido, Japan.
  • Kenmotsu H; Center for Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan.
  • Maeda T; Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Morita S; Division of Thoracic Oncology, Shizuoka Cancer Center, Suntougun, Japan.
  • Sakai D; Division of Precision Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
  • Bando H; Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan.
  • Makiyama A; Center for Cancer Genomics and Personalized Medicine, Osaka University Hospital, Suita, Japan.
  • Suzuki T; Translational Research Support Section, National Cancer Center Hospital East, Kashiwa, Japan.
  • Hirata M; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Kohsaka S; Cancer Center, Gifu University Hospital, Gifu, Japan.
  • Tsuchihara K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Naito Y; Department of Genetic Medicine and Services, National Cancer Center Hospital, Tokyo, Japan.
  • Yoshino T; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.
Cancer Sci ; 113(11): 3646-3656, 2022 Nov.
Article en En | MEDLINE | ID: mdl-35876224
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ADN Tumoral Circulante / Neoplasias Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Cancer Sci Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ADN Tumoral Circulante / Neoplasias Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Cancer Sci Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido